Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.
The current price of BIO-B is $309.37 USD — it has increased by +3.64% in the past 24 hours. Watch Bio-Rad Laboratories stock price performance more closely on the chart.
What is Bio-Rad Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bio-Rad Laboratories stocks are traded under the ticker BIO-B.
What is Bio-Rad Laboratories market cap?▼
Today Bio-Rad Laboratories has the market capitalization of 6.71B
When is the next Bio-Rad Laboratories earnings date?▼
Bio-Rad Laboratories is going to release the next earnings report on July 30, 2026.
What were Bio-Rad Laboratories earnings last quarter?▼
BIO-B earnings for the last quarter are 1.89 USD per share, whereas the estimation was 1.97 USD resulting in a -4.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bio-Rad Laboratories revenue for the last year?▼
Bio-Rad Laboratories revenue for the last year amounts to 2.57B USD.
What is Bio-Rad Laboratories net income for the last year?▼
BIO-B net income for the last year is -1.84B USD.
How many employees does Bio-Rad Laboratories have?▼
As of July 18, 2026, the company has 7,700 employees.
In which sector is Bio-Rad Laboratories located?▼
Bio-Rad Laboratories operates in the Health & Wellness sector.
When did Bio-Rad Laboratories complete a stock split?▼
Bio-Rad Laboratories has not had any recent stock splits.
Where is Bio-Rad Laboratories headquartered?▼
Bio-Rad Laboratories is headquartered in Hercules, United States.